These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31309498)

  • 21. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
    Zhao H; Li X; Johnson DE; Mobley HLT
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deacidification by FhlA-dependent hydrogenase is involved in urease activity and urinary stone formation in uropathogenic Proteus mirabilis.
    Lin WY; Liaw SJ
    Sci Rep; 2020 Nov; 10(1):19546. PubMed ID: 33177598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements.
    Armbruster CE; Forsyth-DeOrnellas V; Johnson AO; Smith SN; Zhao L; Wu W; Mobley HLT
    PLoS Pathog; 2017 Jun; 13(6):e1006434. PubMed ID: 28614382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. d-Serine Degradation by Proteus mirabilis Contributes to Fitness during Single-Species and Polymicrobial Catheter-Associated Urinary Tract Infection.
    Brauer AL; White AN; Learman BS; Johnson AO; Armbruster CE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30814316
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of urease activity in the urinary tract pathogens Staphylococcus saprophyticus and Proteus mirabilis by dimethylsulfoxide (DMSO).
    Deutch CE
    J Appl Microbiol; 2020 May; 128(5):1514-1523. PubMed ID: 31860153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H; Thompson RB; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
    Jones BD; Lockatell CV; Johnson DE; Warren JW; Mobley HL
    Infect Immun; 1990 Apr; 58(4):1120-3. PubMed ID: 2180821
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Pawar S; Ashraf MI; Mujawar S; Mishra R; Lahiri C
    Front Cell Infect Microbiol; 2018; 8():269. PubMed ID: 30131943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A; Rozalski A
    Microbiol Res; 2014; 169(7-8):579-84. PubMed ID: 24239192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.
    Li X; Zhao H; Lockatell CV; Drachenberg CB; Johnson DE; Mobley HL
    Infect Immun; 2002 Jan; 70(1):389-94. PubMed ID: 11748205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.
    Milo S; Heylen RA; Glancy J; Williams GT; Patenall BL; Hathaway HJ; Thet NT; Allinson SL; Laabei M; Jenkins ATA
    Sci Rep; 2021 Feb; 11(1):3726. PubMed ID: 33580163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cranberry impairs selected behaviors essential for virulence in Proteus mirabilis HI4320.
    McCall J; Hidalgo G; Asadishad B; Tufenkji N
    Can J Microbiol; 2013 Jun; 59(6):430-6. PubMed ID: 23750959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
    Pearson MM; Sebaihia M; Churcher C; Quail MA; Seshasayee AS; Luscombe NM; Abdellah Z; Arrosmith C; Atkin B; Chillingworth T; Hauser H; Jagels K; Moule S; Mungall K; Norbertczak H; Rabbinowitsch E; Walker D; Whithead S; Thomson NR; Rather PN; Parkhill J; Mobley HL
    J Bacteriol; 2008 Jun; 190(11):4027-37. PubMed ID: 18375554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteus mirabilis strains of diverse type have IgA protease activity.
    Senior BW; Albrechtsen M; Kerr MA
    J Med Microbiol; 1987 Sep; 24(2):175-80. PubMed ID: 3309325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done.
    Stickler DJ
    J Intern Med; 2014 Aug; 276(2):120-9. PubMed ID: 24635559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Proteus mirabilis urinary tract infection.
    Coker C; Poore CA; Li X; Mobley HL
    Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.